Pauza Charles David
SEC CIK 2018150 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | CSO Virology | 116.0K | — | — | 2 | 2024-04-01 | 2025-12-12 |
Most active insiders at TRAW, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | $998.2K | — |
| 2 | Parker Charles Nolan | CFO | — | — |
| 3 | Redfield Robert | Chief Medical Off | — | — |
| 4 | Pauza Charles David | CSO Virology | — | — |
| 5 | Savchuk Nikolay | COO, Dir | — | — |
| 6 | Clarke Trafford | Dir | — | — |
| 7 | Shoemaker Mary Teresa | Dir | — | — |
| 8 | Dukes Iain D. | CEO, Dir | — | — |
| 9 | Leaman John Harold | Dir | — | — |
| 10 | CAUTREELS WERNER | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-16 | 2025-12-12 | TRAW | Traws Pharma, Inc. | Pauza Charles David | CSO Virology | A - Grant | $0.00 | +18.5K | 116.0K | +19% | $0 |
| D | 2024-04-03 | 2024-04-01 | TRAW | Traws Pharma, Inc. | Pauza Charles David | CSO Virology | A - Grant | — | +97.5K | 97.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations